Purified anti-SUZ12 Antibody, SUZ12, W22172F,BioLegend,647051

This antibody (clone W22172C) is not suitable for immunocytochemistry (ICC) or immunohistochemistry (IHC).

Host

Rat

Reactivity

Human, Mouse, Rat

Application

WB - Quality tested

Platform ID

BAB774518841

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-SUZ12 Antibody, SUZ12, W22172F
Cat. No.647051
HostRat
RRIDAB_3662328 (BioLegend Cat. No. 647051)AB_3662328 (BioLegend Cat. No. 647052)
IsotypeRat IgG2a, κ
ReactivityHuman, Mouse, Rat
ApplicationWB - Quality tested
ClonalityMonoclonal
Clone NumberW22172F
Concentration0.5 mg/mL
TargetSUZ12
ImmunogenRecombinant fragment of human SUZ12
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

The SUZ12 protein is a key component of the Polycomb Repressive Complex 2 (PRC2), a major player in gene silencing through histone modification. SUZ12 is essential for the PRC2 complex's ability to methylate histone H3 at lysine 27 (H3K27me3). This methylation marks chromatin for repression, leading to transcriptional silencing of target genes. By contributing to the formation of H3K27me3 marks, SUZ12 helps maintain the repression of genes involved in various cellular processes including development, differentiation, and cell cycle regulation. SUZ12 and the PRC2 complex are crucial for normal embryonic development. They regulate the expression of genes necessary for maintaining pluripotency in embryonic stem cells and for proper lineage commitment during development. Abnormal SUZ12 expression or function are linked to various cancers. SUZ12, as part of PRC2, can act as an oncogene or tumor suppressor, depending on the context. Its deregulation can lead to inappropriate gene silencing or activation, contributing to tumorigenesis.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.